202 related articles for article (PubMed ID: 35650297)
1. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
[TBL] [Abstract][Full Text] [Related]
2. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis of potential hub genes in gastric adenocarcinoma.
Liu H; Qu Y; Zhou H; Zheng Z; Zhao J; Zhang J
Sci Prog; 2021; 104(1):368504211004260. PubMed ID: 33788653
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
Huang J; Wen F; Huang W; Bai Y; Lu X; Shu P
Biomark Med; 2020 Aug; 14(12):1069-1084. PubMed ID: 32969243
[No Abstract] [Full Text] [Related]
9. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
Chen F; Wang Y; Zhang X; Fang J
Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
11. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer.
Xu J; Wang X; Ke Q; Liao K; Wan Y; Zhang K; Zhang G; Wang X
Sci Rep; 2021 Jul; 11(1):15412. PubMed ID: 34326374
[TBL] [Abstract][Full Text] [Related]
12. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis.
Wang S; Tao S; Liu Y; Shi Y; Liu M
J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425
[TBL] [Abstract][Full Text] [Related]
13. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
[TBL] [Abstract][Full Text] [Related]
14. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
Alatan H; Chen Y; Zhou J; Wang L
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
[TBL] [Abstract][Full Text] [Related]
16. [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].
Yang W; Pan Y; Guan P; Li X; You C
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):540-546. PubMed ID: 31140417
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
18. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer.
Li Y; Chen M; Chen Q; Yuan M; Zeng X; Zeng Y; He M; Wang B; Han B
Adv Ther; 2023 Apr; 40(4):1456-1473. PubMed ID: 36694099
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis.
Qi W; Sun L; Liu N; Zhao S; Lv J; Qiu W
Mol Med Rep; 2018 Oct; 18(4):3599-3610. PubMed ID: 30106120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]